Dasashil 100 mg Tablet

Dasashil 100 mg Tablet contains dasatinib 100 mg, a targeted anticancer medicine belonging to the tyrosine kinase inhibitor class. It is used to treat certain blood cancers, including chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia. The tablet is taken orally with or without food according to the treatment plan prescribed by an oncologist.

BUY NOW

Category

Dasatinib works by inhibiting abnormal tyrosine kinases, including BCR-ABL, that promote the growth and survival of leukemia cells. Dasashil 100 mg is used in specific treatment settings for Philadelphia chromosome-positive leukemia. The product is manufactured by Shilpa Medicare Limited and is supplied in a bottle containing 30 tablets. Regular medical monitoring may be required during treatment to assess blood counts and other treatment-related effects.

Technical Specification

Specification Details
Active Ingredient Dasatinib
Strength 100 mg
Dosage Form Tablet
Route of Administration Oral
Pack Size 30 tablets
Manufacturer Shilpa Medicare Limited

Product Also Known As

Dasashil 100 mg Tablet, Dasashil 100mg Tablet, Dasatinib 100 mg Tablet, Dasatinib 100mg Tablet, Dasatinib Anticancer Tablet, Dasatinib Leukemia Tablet, BCR-ABL Inhibitor Tablet